Make an Appointment
-
Marc Mayberg, MD550 17th Avenue, Suite 500, Seattle, WA 98122 map
-
Swedish Health Services1101 Madison Street, Suite 200, Seattle, WA 98104 map
Dr. Marc Mayberg is a neurosurgeon in Seattle. He provides surgical treatments for a range of conditions affecting the nervous system, such as epilepsy and Parkinson's disease.
Marc Mayberg, MD
Accepting New Patients?
Yes, Dr. Marc R. Mayberg is accepting new patients at this office.
Phone
Fax
(206) 320-2827
Address
550 17th Avenue, Suite 500, Seattle, WA 98122
Office Details
Swedish Health Services
Please Note: This link will direct you to a third-party website unaffiliated with MD.com (https://mychart.swedish.org/mychart/), where you're able to request or schedule an appointment online with Dr. Marc Mayberg.
Accepting New Patients?
Yes, Dr. Marc R. Mayberg is accepting new patients at this office.
Phone
Fax
(206) 386-2149
Address
1101 Madison Street, Suite 200, Seattle, WA 98104-1321
Office Details
Insurance Accepted
- Medicare
Bio
Dr. Marc Mayberg graduated from Mayo Clinic School of Medicine in 1978.
Dr. Mayberg has two offices in Washington where he specializes in Neurosurgery.
Dr. Mayberg works with four hundred and eleven doctors including Dr. Melissa Hayes-balmadrid and Dr. Mariann Drucker.
Specialty
-
Neurosurgery
As a neurosurgeon, Dr. Mayberg is trained to perform highly technical surgeries to correct disorders of the central, autonomic or peripheral nervous systems. He may provide both invasive and minimally-invasive surgical treatment options, depending upon the patient's condition. Neurosurgeons may treat spinal disorders, traumatic brain injuries, tumors, Parkinson's disease, and more.
Education & Training
Hospital Affiliations
- Swedish Health Services
Languages Spoken
- English
Latest Neurosurgery News
-
Sleep, Don't Cram, Before Finals for Better GradesAmy Norton, HealthDay Reporter, Dec 10, 2018 at 12:00 PM
-
Catnip: The 'Why' Behind Cats' Favorite HighRobert Preidt, Dec 10, 2018 at 12:00 PM
-
FDA Warns of Rare Stroke Risk With MS DrugRobert Preidt, Dec 5, 2018 at 2:00 PM